Evidence map›Paper›PMID 40400535›Full record

ArticleOncology letters2025

Establishment and evaluation of an automatic multi?sequence MRI segmentation model of primary central nervous system lymphoma based on the nnU?Net deep learning network method.

Tao Wang, Xingru Tang, Jun Du, Yongqian Jia, Weiwei Mou, Guang Lu

Abstract read
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tao WangDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Xingru TangDepartment of Clinical Medicine, Shanghai Jiao Tong University, Shanghai 200030, P.R. China.
Jun DuDepartment of Hematology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai 200001, P.R. China.
Yongqian JiaDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Weiwei MouDepartment of Pediatrics, Shengli Oilfield Central Hospital, Dongying, Shandong 257099, P.R. China.
Guang LuDepartment of Hematology, Shandong Second Provincial General Hospital, Jinan, Shandong 250022, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate quantitative assessment using gadolinium-contrast magnetic resonance imaging (MRI) is crucial in therapy planning, surveillance and prognostic assessment of primary central nervous system lymphoma (PCNSL). The present study aimed to develop a multimodal artificial intelligence deep learning segmentation model to address the challenges associated with traditional 2D measurements and manual volume assessments in MRI. Data from 49 pathologically-confirmed patients with PCNSL from six Chinese medical centers were analyzed, and regions of interest were manually segmented on contrast-enhanced T1-weighted and T2-weighted MRI scans for each patient, followed by fully automated voxel-wise segmentation of tumor components using a 3-dimenstional convolutional deep neural network. Furthermore, the efficiency of the model was evaluated using practical indicators and its consistency and accuracy was compared with traditional methods. The performance of the models were assessed using the Dice similarity coefficient (DSC). The Mann-Whitney U test was used to compare continuous clinical variables and the χ

Indexed as

automated segmentationsdeep learning modelmagnetic resonance imagingprimary central nervous system lymphoma

Identifiers

PMID40400535
PMCPMC12093087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.